BridgeMD
New treatment option for Scarring Alopecia
Official title 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
ClinicalTrials.gov ID: NCT05460611
What this study is testing
- What it's testing
- Single-center, open-label, baseline-controlled, pilot study evaluating the use of a Nonablative 1470 nm laser for the treatment of androgenetic alopecia and scarring alopecia.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99. Healthy volunteers may be eligible.
You may be able to join if
- Healthy males and females, ≥ 18 years of age at time of informed consent, seeking treatment for hair loss
- Subject must voluntarily sign and date an IRB approved informed consent form
- people with diagnosis of biopsy proven androgenetic alopecia or scarring alopecia with hair loss recorded over the past 6 months
- people must have a stable hair loss treatment regimen with a plateau in results for at least 3 months
- Able to read, understand and voluntarily provide written informed consent
You likely can't join if
- Subject does not have the capacity to consent to the study
- Subject has other types of alopecia of the scalp like alopecia areata
- History of intralesional steroid injections to the scalp in the last 12 months
- Pregnant women
- Any medical condition that in the consideration of the investigator, would present an increased risk of a photosensitivity reaction to the subject
- Any previous surgical procedure in the treatment area in the past 12 months, or major surgery in the last 6 months
See the full eligibility criteria
- Healthy males and females, ≥ 18 years of age at time of informed consent, seeking treatment for hair loss
- Subject must voluntarily sign and date an IRB approved informed consent form
- people with diagnosis of biopsy proven androgenetic alopecia or scarring alopecia with hair loss recorded over the past 6 months
- people must have a stable hair loss treatment regimen with a plateau in results for at least 3 months
- Able to read, understand and voluntarily provide written informed consent
- Subject is determined to be healthy, non-smoker who agrees not to make any changes to their daily hair treatment regimen during the study
- people able and willing to comply with the treatment protocol and follow-up schedule and requirements
- Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period
- Subject does not have the capacity to consent to the study
- Subject has other types of alopecia of the scalp like alopecia areata
- History of intralesional steroid injections to the scalp in the last 12 months
- Pregnant women
- Any medical condition that in the consideration of the investigator, would present an increased risk of a photosensitivity reaction to the subject
- Any previous surgical procedure in the treatment area in the past 12 months, or major surgery in the last 6 months
- Allergy or history of prior reaction to lidocaine
- History of immunosuppression/immune deficiency disorders (including AIDS and HIV infection), and/or any history of systemic chemotherapy for prior 12 months
- History or current use of the following prescription medications: i. Immunosuppressive medications/biologics, 6 months prior to and during the study ii. Accutane or other systemic retinoids within the past twelve months
- Smoking or vaping in the past 12 months
- History of uncontrolled hyperlipidemia, diabetes mellitus, hepatitis, or bleeding disorders
- History of major depressive disorders or endocrine disorders including but not limited to; hypothyroidism, Hashimoto's thyroiditis, or hyperthyroidism
The study team makes the final eligibility decision.
Where it's taking place
- Elmsford, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Elmsford, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.